Comment & Analysis
Coronavirus
Regulation, Risk & Compliance
Uncategorized
Middle East's life sciences players face high corruption risk
A year on from the Covid-19 outbreak, bribery and corruption remain the top risk facing life sciences businesses in the Middle East. This is according to a new KPMG study among industry-leading companies. KPMG ran surveys and interviews through last year, among life sciences distributors and manufacturers in the Middle…
Continue Reading
Subscribe to unlock the full article and access premium financial content.
Click here to read the full story: Consultancy